Tag: reactiv8-B
Mainstay Medical to showcase ReActiv8 and key clinical data at the...
It has been announced that Mainstay Medical will participate in the upcoming 13th German Spine Congress of the Deutsche Wirbelsäulengesellschaft (DWG; 6—8 December, Wiesbaden,...
Mainstay Medical’s ReActiv8 clinical trial passes enrolment mid-point
Over half the required number of implants in Mainstay Medical’s ReActiv8-B clinical trial have been performed. The clinical trial is investigating the company’s novel...
ReActiv8’s clinically important disability, pain and quality-of-life improvements sustained at one-year
The disruption of lumbar multifidus muscle control is one factor involved in many cases of functional instability and chronic low back pain. Whilst targeted...